Skip to main content
Erschienen in: European Journal of Nutrition 6/2014

01.09.2014 | Original Contribution

The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES

verfasst von: Tristan Struja, Aline Richard, Jakob Linseisen, Monika Eichholzer, Sabine Rohrmann

Erschienen in: European Journal of Nutrition | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Metabolic syndrome is a major risk factor for cardiovascular diseases, which are still the major cause of death in developed countries.

Methods

We cross-sectionally studied the association between urinary phytoestrogen excretion and metabolic cardiovascular risk factors. Hence, we used data from the National Health and Nutrition Examination Survey from 1999 to 2004 with 1,748 participants, who had urine levels of isoflavones and lignans measured. Geometric means of waist circumference, blood pressure, fasting glucose, HDL cholesterol, and triglyceride levels were computed by quartiles of isoflavone or lignan urinary excretion. Outcome was assessed as the presence of metabolic syndrome according to NCEP-ATP III criteria. The association between phytoestrogen concentration and the metabolic syndrome was calculated using logistic regression analyses.

Results

Plasma triglyceride and HDL cholesterol levels were lower in participants in the highest quartile of lignan excretion compared with the lowest (both P < 0.01). However, blood pressure, waist circumference, and plasma glucose levels did not differ significantly between extreme quartiles. The presence of metabolic syndrome was lower with increasing levels of urinary lignans (OR 0.48, 95 % CI 0.28; 0.80 top vs. bottom quartile), especially when separately computed for the excretion of enterolactone (OR 0.47, 95 % CI 0.28; 0.78). There was no significant association between isoflavone excretion and any component of the metabolic syndrome.

Conclusions

Our study shows that an increasing excretion of lignans, especially enterolactone, might be associated with a decreased presence of the metabolic syndrome.
Literatur
1.
Zurück zum Zitat Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40. doi:10.1016/S0140-6736(11)60679-X CrossRef Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40. doi:10.​1016/​S0140-6736(11)60679-X CrossRef
4.
Zurück zum Zitat Saarinen NM, Bingham C, Lorenzetti S et al (2006) Tools to evaluate estrogenic potency of dietary phytoestrogens: a consensus paper from the EU Thematic Network “Phytohealth” (QLKI-2002-2453). Genes Nutr 1(3–4):143–158. doi:10.1007/BF02829964 CrossRef Saarinen NM, Bingham C, Lorenzetti S et al (2006) Tools to evaluate estrogenic potency of dietary phytoestrogens: a consensus paper from the EU Thematic Network “Phytohealth” (QLKI-2002-2453). Genes Nutr 1(3–4):143–158. doi:10.​1007/​BF02829964 CrossRef
5.
Zurück zum Zitat French MR, Thompson LU, Hawker GA (2007) Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J Am Coll Nutr 26(1):76–82CrossRef French MR, Thompson LU, Hawker GA (2007) Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J Am Coll Nutr 26(1):76–82CrossRef
6.
Zurück zum Zitat Frankenfeld CL, Patterson RE, Kalhorn TF et al (2002) Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults. J Am Diet Assoc 102(10):1407–1413CrossRef Frankenfeld CL, Patterson RE, Kalhorn TF et al (2002) Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults. J Am Diet Assoc 102(10):1407–1413CrossRef
8.
Zurück zum Zitat Bar-El DS, Reifen R (2010) Soy as an endocrine disruptor: cause for caution? J Pediatr Endocrinol Metab 23(9):855–861 Bar-El DS, Reifen R (2010) Soy as an endocrine disruptor: cause for caution? J Pediatr Endocrinol Metab 23(9):855–861
11.
14.
Zurück zum Zitat Guthrie JR, Ball M, Murkies A et al (2000) Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric 3(4):254–261CrossRef Guthrie JR, Ball M, Murkies A et al (2000) Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric 3(4):254–261CrossRef
15.
Zurück zum Zitat Jayagopal V, Albertazzi P, Kilpatrick ES et al (2002) Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25(10):1709–1714CrossRef Jayagopal V, Albertazzi P, Kilpatrick ES et al (2002) Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25(10):1709–1714CrossRef
16.
Zurück zum Zitat Greany KA, Nettleton JA, Wangen KE et al (2004) Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 134(12):3277–3283 Greany KA, Nettleton JA, Wangen KE et al (2004) Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 134(12):3277–3283
18.
Zurück zum Zitat Anderson JW, Hoie LH (2005) Weight loss and lipid changes with low-energy diets: comparator study of milk-based versus soy-based liquid meal replacement interventions. J Am Coll Nutr 24(3):210–216CrossRef Anderson JW, Hoie LH (2005) Weight loss and lipid changes with low-energy diets: comparator study of milk-based versus soy-based liquid meal replacement interventions. J Am Coll Nutr 24(3):210–216CrossRef
19.
Zurück zum Zitat Li Z, Hong K, Saltsman P et al (2005) Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 59(3):411–418. doi:10.1038/sj.ejcn.1602089 CrossRef Li Z, Hong K, Saltsman P et al (2005) Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 59(3):411–418. doi:10.​1038/​sj.​ejcn.​1602089 CrossRef
23.
Zurück zum Zitat Bhupathy P, Haines CD, Leinwand LA (2010) Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 6(1):77–95. doi:10.2217/whe.09.80 Bhupathy P, Haines CD, Leinwand LA (2010) Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 6(1):77–95. doi:10.​2217/​whe.​09.​80
24.
Zurück zum Zitat Peñalvo JL, López-Romero P (2012) Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults. J Nutr 142(4):751–756. doi:10.3945/jn.111.150516 CrossRef Peñalvo JL, López-Romero P (2012) Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults. J Nutr 142(4):751–756. doi:10.​3945/​jn.​111.​150516 CrossRef
31.
Zurück zum Zitat Barnes S, Coward L, Kirk M et al (1998) HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med 217(3):254–262CrossRef Barnes S, Coward L, Kirk M et al (1998) HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med 217(3):254–262CrossRef
35.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502 Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
37.
Zurück zum Zitat de Kleijn MJJ, van der Schouw YT, Wilson PWF et al (2002) Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr 132(2):276–282 de Kleijn MJJ, van der Schouw YT, Wilson PWF et al (2002) Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr 132(2):276–282
38.
Zurück zum Zitat Cornish SM, Chilibeck PD, Paus-Jennsen L et al (2009) A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 34(2):89–98. doi:10.1139/H08-142 CrossRef Cornish SM, Chilibeck PD, Paus-Jennsen L et al (2009) A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 34(2):89–98. doi:10.​1139/​H08-142 CrossRef
39.
Zurück zum Zitat Yang G, Shu XO, Jin F et al (2004) Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women’s Health Study. Eur J Clin Nutr 58(4):615–620. doi:10.1038/sj.ejcn.1601855 CrossRef Yang G, Shu XO, Jin F et al (2004) Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women’s Health Study. Eur J Clin Nutr 58(4):615–620. doi:10.​1038/​sj.​ejcn.​1601855 CrossRef
40.
Zurück zum Zitat Goodman-Gruen D, Kritz-Silverstein D (2001) Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131(4):1202–1206 Goodman-Gruen D, Kritz-Silverstein D (2001) Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131(4):1202–1206
41.
Zurück zum Zitat Kuijsten A, Arts ICW, Vree TB et al (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135(4):795–801 Kuijsten A, Arts ICW, Vree TB et al (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135(4):795–801
42.
Zurück zum Zitat Setchell KDR, Faughnan MS, Avades T et al (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77(2):411–419 Setchell KDR, Faughnan MS, Avades T et al (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77(2):411–419
43.
Zurück zum Zitat Bloedon LT, Jeffcoat AR, Lopaczynski W et al (2002) Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 76(5):1126–1137 Bloedon LT, Jeffcoat AR, Lopaczynski W et al (2002) Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 76(5):1126–1137
45.
Zurück zum Zitat Valentín-Blasini L, Blount BC, Caudill SP et al (2003) Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13(4):276–282. doi:10.1038/sj.jea.7500278 CrossRef Valentín-Blasini L, Blount BC, Caudill SP et al (2003) Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13(4):276–282. doi:10.​1038/​sj.​jea.​7500278 CrossRef
47.
Zurück zum Zitat Merritt JC (2004) Metabolic syndrome: soybean foods and serum lipids. J Natl Med Assoc 96(8):1032–1041 Merritt JC (2004) Metabolic syndrome: soybean foods and serum lipids. J Natl Med Assoc 96(8):1032–1041
49.
50.
Zurück zum Zitat Heo M, Kim RS, Wylie-Rosett J et al (2011) Inverse association between fruit and vegetable intake and BMI even after controlling for demographic, socioeconomic and lifestyle factors. Obes Facts 4(6):449–455. doi:10.1159/000335279 CrossRef Heo M, Kim RS, Wylie-Rosett J et al (2011) Inverse association between fruit and vegetable intake and BMI even after controlling for demographic, socioeconomic and lifestyle factors. Obes Facts 4(6):449–455. doi:10.​1159/​000335279 CrossRef
51.
Zurück zum Zitat Lutfiyya MN, Chang LF, Lipsky MS (2012) A cross-sectional study of US rural adults’ consumption of fruits and vegetables: do they consume at least five servings daily? BMC Public Health 12:280. doi:10.1186/1471-2458-12-280 CrossRef Lutfiyya MN, Chang LF, Lipsky MS (2012) A cross-sectional study of US rural adults’ consumption of fruits and vegetables: do they consume at least five servings daily? BMC Public Health 12:280. doi:10.​1186/​1471-2458-12-280 CrossRef
53.
Zurück zum Zitat Vergne S, Sauvant P, Lamothe V et al (2009) Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br J Nutr 102(11):1642. doi:10.1017/S0007114509990833 CrossRef Vergne S, Sauvant P, Lamothe V et al (2009) Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br J Nutr 102(11):1642. doi:10.​1017/​S000711450999083​3 CrossRef
54.
Zurück zum Zitat Kunisue T, Tanabe S, Isobe T et al (2010) Profiles of phytoestrogens in human urine from several Asian countries. J Agric Food Chem 58(17):9838–9846. doi:10.1021/jf102253j CrossRef Kunisue T, Tanabe S, Isobe T et al (2010) Profiles of phytoestrogens in human urine from several Asian countries. J Agric Food Chem 58(17):9838–9846. doi:10.​1021/​jf102253j CrossRef
55.
57.
Zurück zum Zitat Cederroth CR, Vinciguerra M, Gjinovci A et al (2008) Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57(5):1176–1185. doi:10.2337/db07-0630 CrossRef Cederroth CR, Vinciguerra M, Gjinovci A et al (2008) Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57(5):1176–1185. doi:10.​2337/​db07-0630 CrossRef
58.
Zurück zum Zitat Aoyama T, Fukui K, Nakamori T et al (2000) Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 64(12):2594–2600CrossRef Aoyama T, Fukui K, Nakamori T et al (2000) Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 64(12):2594–2600CrossRef
59.
Zurück zum Zitat Choi MS, Jung UJ, Yeo J et al (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24(1):74–81. doi:10.1002/dmrr.780 CrossRef Choi MS, Jung UJ, Yeo J et al (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24(1):74–81. doi:10.​1002/​dmrr.​780 CrossRef
61.
Zurück zum Zitat Marinangeli CPF, Jones PJH (2011) Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. Br J Nutr 105(1):110–117. doi:10.1017/S0007114510003156 CrossRef Marinangeli CPF, Jones PJH (2011) Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. Br J Nutr 105(1):110–117. doi:10.​1017/​S000711451000315​6 CrossRef
62.
Zurück zum Zitat Hall WL, Vafeiadou K, Hallund J et al (2006) Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83(3):592–600 Hall WL, Vafeiadou K, Hallund J et al (2006) Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83(3):592–600
64.
Zurück zum Zitat Rosero Arenas MA, Rosero Arenas E, Portaceli Armiñana MA et al (2008) Utilidad de los fitoestrógenos en la reducción de la presión arterial. Revisión sistemática y metaanálisis (Usefulness of phyto-oestrogens in reduction of blood pressure. Systematic review and meta-analysis). Aten Primaria 40(4):177–186CrossRef Rosero Arenas MA, Rosero Arenas E, Portaceli Armiñana MA et al (2008) Utilidad de los fitoestrógenos en la reducción de la presión arterial. Revisión sistemática y metaanálisis (Usefulness of phyto-oestrogens in reduction of blood pressure. Systematic review and meta-analysis). Aten Primaria 40(4):177–186CrossRef
65.
Zurück zum Zitat Taddei S (2009) Blood pressure through aging and menopause. Climacteric 12(Suppl 1):36–40CrossRef Taddei S (2009) Blood pressure through aging and menopause. Climacteric 12(Suppl 1):36–40CrossRef
66.
Zurück zum Zitat Weggemans RM, Trautwein EA (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57(8):940–946. doi:10.1038/sj.ejcn.1601628 CrossRef Weggemans RM, Trautwein EA (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57(8):940–946. doi:10.​1038/​sj.​ejcn.​1601628 CrossRef
67.
Zurück zum Zitat McPherson R, Frohlich J, Fodor G et al (2006) Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22(11):913–927CrossRef McPherson R, Frohlich J, Fodor G et al (2006) Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22(11):913–927CrossRef
68.
Zurück zum Zitat Erberich LCN, Alcantara VM, Picheth G et al (2002) Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels. Clin Chem Lab Med 40(5):446–451. doi:10.1515/CCLM.2002.076 Erberich LCN, Alcantara VM, Picheth G et al (2002) Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels. Clin Chem Lab Med 40(5):446–451. doi:10.​1515/​CCLM.​2002.​076
Metadaten
Titel
The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES
verfasst von
Tristan Struja
Aline Richard
Jakob Linseisen
Monika Eichholzer
Sabine Rohrmann
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 6/2014
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-013-0639-y

Weitere Artikel der Ausgabe 6/2014

European Journal of Nutrition 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.